Fierstein Jeffrey MD is categorized under Ear Nose and Throat Doctors in Granite City, IL and active since 1979.
Fierstein Jeffrey MD was established in 1979, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Ear Nose and Throat Doctors business, which does work in the B2C market, and is classified as a Ear Nose and Throat Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Jeffrey Fierstein at the company’s single location by writing to 2120 Madison Avenue # 200, Granite City, Illinois IL 62040 or by phoning (618) 451-1800. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Fierstein Jeffrey MD |
| Contact Person: | Jeffrey Fierstein |
| Address: | 2120 Madison Avenue # 200, Granite City, Illinois 62040 |
| Phone Number: | (618) 451-1800 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 1979 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Ear Nose and Throat Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Fierstein Jeffrey MD was started in 1979 to provide professional Ear Nose and Throat Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Jeffrey Fierstein for inquiries that concern Fierstein Jeffrey MD by calling the company number (618) 451-1800, as your correspondence is most welcome. Additionally, the physical location of the single location of Fierstein Jeffrey MD can be found at the coordinates 38.701211,-90.144442 as well as the street address 2120 Madison Avenue # 200 in Granite City, Illinois 62040.
For its online presence, you may visit Fierstein Jeffrey MD’s website at and engage with its social media outlets through on Twitter and on Facebook.